98 related articles for article (PubMed ID: 17203214)
1. Repression of cyclin D1 as a target for germ cell tumors.
Freemantle SJ; Vaseva AV; Ewings KE; Bee T; Krizan KA; Kelley MR; Hattab EM; Memoli VA; Black CC; Spinella MJ; Dmitrovsky E
Int J Oncol; 2007 Feb; 30(2):333-40. PubMed ID: 17203214
[TBL] [Abstract][Full Text] [Related]
2. Retinoid targeting of different D-type cyclins through distinct chemopreventive mechanisms.
Ma Y; Feng Q; Sekula D; Diehl JA; Freemantle SJ; Dmitrovsky E
Cancer Res; 2005 Jul; 65(14):6476-83. PubMed ID: 16024653
[TBL] [Abstract][Full Text] [Related]
3. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor receptor tyrosine kinase inhibition represses cyclin D1 in aerodigestive tract cancers.
Petty WJ; Dragnev KH; Memoli VA; Ma Y; Desai NB; Biddle A; Davis TH; Nugent WC; Memoli N; Hamilton M; Iwata KK; Rigas JR; Dmitrovsky E
Clin Cancer Res; 2004 Nov; 10(22):7547-54. PubMed ID: 15569985
[TBL] [Abstract][Full Text] [Related]
5. Derivation and characterization of retinoid-resistant human embryonal carcinoma cells.
Moasser MM; Khoo KS; Maerz WJ; Zelenetz A; Dmitrovsky E
Differentiation; 1996 Jul; 60(4):251-7. PubMed ID: 8765055
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation.
Spinella MJ; Freemantle SJ; Sekula D; Chang JH; Christie AJ; Dmitrovsky E
J Biol Chem; 1999 Jul; 274(31):22013-8. PubMed ID: 10419526
[TBL] [Abstract][Full Text] [Related]
7. Cyclin proteolysis as a retinoid cancer prevention mechanism.
Dragnev KH; Freemantle SJ; Spinella MJ; Dmitrovsky E
Ann N Y Acad Sci; 2001 Dec; 952():13-22. PubMed ID: 11795432
[TBL] [Abstract][Full Text] [Related]
8. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
[TBL] [Abstract][Full Text] [Related]
9. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function.
Curtin JC; Dragnev KH; Sekula D; Christie AJ; Dmitrovsky E; Spinella MJ
Oncogene; 2001 May; 20(20):2559-69. PubMed ID: 11420666
[TBL] [Abstract][Full Text] [Related]
10. Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.
De Giorgi U; Yuan J; Moroni M; Veronese S; Sartore-Bianchi A; Broggini M; Rosti G; Strebhardt K; Ruffini PA
Int J Biol Markers; 2015 Jul; 30(3):e275-81. PubMed ID: 25982682
[TBL] [Abstract][Full Text] [Related]
11. all-trans retinoic acid for treating germ cell tumors. In vitro activity and results of a phase II trial.
Moasser MM; Motzer RJ; Khoo KS; Lyn P; Murphy BA; Bosl GJ; Dmitrovsky E
Cancer; 1995 Aug; 76(4):680-6. PubMed ID: 8625166
[TBL] [Abstract][Full Text] [Related]
12. Response and resistance to retinoic acid are mediated through the retinoic acid nuclear receptor gamma in human teratocarcinomas.
Moasser MM; DeBlasio A; Dmitrovsky E
Oncogene; 1994 Mar; 9(3):833-40. PubMed ID: 8108126
[TBL] [Abstract][Full Text] [Related]
13. Specific chemopreventive agents trigger proteasomal degradation of G1 cyclins: implications for combination therapy.
Dragnev KH; Pitha-Rowe I; Ma Y; Petty WJ; Sekula D; Murphy B; Rendi M; Suh N; Desai NB; Sporn MB; Freemantle SJ; Dmitrovsky E
Clin Cancer Res; 2004 Apr; 10(7):2570-7. PubMed ID: 15073138
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin-dependent inhibitor p27.
Baldassarre G; Boccia A; Bruni P; Sandomenico C; Barone MV; Pepe S; Angrisano T; Belletti B; Motti ML; Fusco A; Viglietto G
Cell Growth Differ; 2000 Oct; 11(10):517-26. PubMed ID: 11063125
[TBL] [Abstract][Full Text] [Related]
15. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis regulation and spontaneous apoptosis index of testicular germ cell tumors are associated with differentiation and resistance to systemic treatment.
Mandoky L; Szende B; Géczi L; Bodrogi I; Kásler M; Bak M
Anticancer Res; 2008; 28(3A):1641-9. PubMed ID: 18630521
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
18. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
[TBL] [Abstract][Full Text] [Related]
20. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
